← Back to Search

Dietary Supplement

Chitin Fiber for Irritable Bowel Syndrome (GGG Trial)

N/A

Waitlist Available

Led By Tiffany Weir, MSc,PhD

Research Sponsored by Colorado State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must be 18 years of age or older with a medical diagnosis of Irritable Bowel Syndrome (IBS) and/or recurrent abdominal pain greater than 1 time per week persistent for at least 3 months while also meeting 2 of the 3 criteria for IBS diagnosis according to the Rome IV assessment

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the time commitment for the study is approximately two and a half months, during which participants will spend ~1 hour (15-20 min/visit) at clinic appointments, eat small chocolate bars containing either the cricket chitin or a maltodextrin placebo daily

Awards & highlights

GGG Trial Summary

This trial aims to investigate the effects of consuming cricket-derived chitin on individuals with Irritable Bowel Syndrome (IBS). Previous research has shown that consuming cricket powder may have prebiotic effects and

Who is the study for?

This trial is for individuals with Irritable Bowel Syndrome (IBS). Participants will consume cricket-derived chitin daily to see if it helps their gut health and quality of life. To join, they must be adults diagnosed with IBS.Check my eligibility

What is being tested?

The study tests the effects of consuming 4 grams of cricket-derived chitin fiber versus a placebo over 30 days on gut health in IBS patients. It aims to see if this unique form of fiber can reduce symptoms and inflammation.See study design

What are the potential side effects?

Potential side effects may include allergic reactions due to insect protein, digestive discomfort or changes in bowel habits given that the intervention involves dietary fiber.

GGG Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 and have been diagnosed with IBS or have had stomach pain more than once a week for the last 3 months.

GGG Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the time commitment for the study is approximately two and a half months, during which participants will spend ~1 hour (15-20 min/visit) at clinic appointments, eat small chocolate bars containing either the cricket chitin or a maltodextrin placebo daily

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the time commitment for the study is approximately two and a half months, during which participants will spend ~1 hour (15-20 min/visit) at clinic appointments, eat small chocolate bars containing either the cricket chitin or a maltodextrin placebo daily

This trial's timeline: 3 weeks for screening, Varies for treatment, and the time commitment for the study is approximately two and a half months, during which participants will spend ~1 hour (15-20 min/visit) at clinic appointments, eat small chocolate bars containing either the cricket chitin or a maltodextrin placebo daily for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Examine the impact that consuming 4 grams of cricket-derived chitin daily for 30 days has on the gut microbiota, intestinal and systemic markers of inflammation, and symptom severity and quality of life in individuals with IBS.

GGG Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Chitin FiberActive Control1 Intervention

Chitin Fiber

Group II: PlaceboPlacebo Group1 Intervention

Maltodextrin

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonOTHER

1,192 Previous Clinical Trials

3,161,981 Total Patients Enrolled

Colorado State UniversityLead Sponsor

126 Previous Clinical Trials

38,359 Total Patients Enrolled

Tiffany Weir, MSc,PhDPrincipal InvestigatorColorado State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers actively seeking participants for this study at the moment?

"According to clinicaltrials.gov, the current status of this trial does not involve patient recruitment. The study was first published on July 6th, 2023 and last revised on April 30th, 2024. While this particular trial is inactive in terms of patient enrollment currently, it's important to note that there are a total of 127 ongoing studies actively seeking participants at present."

Answered by AI